Postoperative outcomes following cardiac surgery in non-anaemic iron-replete and iron-deficient patients – an exploratory study

Anaesthesia

Volumn 73, Issue 4, 2018, Pages 450-458

  Miles, L F ^a   Kunz, S A ^a   Na, L H ^a   Braat, S ^a   Burbury, K ^a   Story, D A ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

anaemia: iron deficiency; cardiac surgical procedures; iron; outcome assessment (healthcare)

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN; TRANSFERRIN SATURATION; UNCLASSIFIED DRUG;

AGED; ALLOTRANSPLANTATION; ARTICLE; BLOOD TRANSFUSION; BODY MASS; BODY SURFACE; CARDIOPULMONARY BYPASS; CLINICAL OUTCOME; COHORT ANALYSIS; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; ESTIMATED GLOMERULAR FILTRATION RATE; EUROSCORE; FEMALE; FERRITIN BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HEART VALVE REPLACEMENT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; INTENSIVE CARE; INTESTINE ISCHEMIA; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; NEUROLOGIC DISEASE; OPERATIVE BLOOD LOSS; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; SUBACUTE CARE; SURGICAL RISK; WOUND INFECTION; AUSTRALIA; DEFICIENCY; EPIDEMIOLOGY; FACTUAL DATABASE; MIDDLE AGED; MISSOURI; MORTALITY; NEW ZEALAND; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; AUSTRALIA; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; DATABASES, FACTUAL; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IRON; LENGTH OF STAY; MALE; MIDDLE AGED; MISSOURI; NEW ZEALAND; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85036592558     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.14115     Document Type: Article

References (27)

1. Hung M, Ortmann E, Besser M, et al. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients. Heart 2015; 101: 107–12.
2. Melenovsky V, Petrak J, Mracek T, et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. European Journal of Heart Failure 2017; 19: 522–30.
3. Favrat B, Balck K, Breymann C, et al. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women – PREFER a randomized, placebo-controlled study. PLoS ONE 2014; 9: e94217.
4. Pratt JJ, Khan KS. Non-anaemic iron deficiency – a disease looking for recognition of diagnosis: a systematic review. European Journal of Haematology 2015; 96: 1–11.
5. Munoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2016; 72: 233–47.
6. National Blood Authority. Perioperative patient blood management guidelines: module 2. 2012. http://www.blood.gov.au/system/files/documents/pbm-module-2.pdf (accessed 10/03/2017).
7. Piednoir P, Allou N, Driss F, et al. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients. European Journal of Anaesthesiology 2011; 28: 796–801.
8. Chan M. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. World Health Organization 2011. http://www.who.int/vmnis/indicators/haemoglobin/en/ (accessed 10/03/2017).
9. Fitzsimons S, Doughty RN. Iron deficiency in patients with heart failure. European Heart Journal 2015; 1: 58–64.
10. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. PLoS Medicine 2007; 4: e296.
11. Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. Journal of Research and Medical Science 2014; 19: 164–74.
12. 2 max, endurance, and blood lactate in women. Medical Science Sports Exercise 1993; 25: 1386–92.
13. Brownlie T, Hinton PS, Giordano C, Haas JD. Effect of iron treatment on adaptation to physical training in marginally iron-deficient non-anemic women. FASEB Journal 1999; 13: A572.
14. Hinton PS, Giordano C, Brownlie T, Haas JD. Iron supplementation improves endurance after training in iron-depleted, nonanemic women. Journal of Applied Physiology 2000; 88: 1103–11.
15. Brownlie T, Utermohlen V, Hinton PS, Haas JD. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. American Journal of Clinical Nutrition 2004; 79: 437–43.
16. Brownlie T, Utermohlen V, Hinton PS, Giordano C, Haas JD. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. American Journal of Clinical Nutrition 2002; 75: 734–42.
17. Okonko DO, Grzeslo A, Witkowski T, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and non-anemic patients with symptomatic chronic heart failure and iron deficiency: a randomised, controlled, observer-blinded trial (FERRIC-HF). Circulation 2006; 114: 407.
18. Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. New England Journal Medicine 2009; 361: 2436–48.
19. Okonko DO, Witkowski T, Mandal AK, et al. Effect of intravenous iron sucrose on exercise tolerance in anaemic and non-anaemic iron deficient patients with chronic heart failure: a randomised, controlled, observer-blinded trial (FERRIC-HF). European Heart Journal 2006; 27: S167.
20. Jankowska EA, Tkaczyszyn M, Suchocki T, et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. European Journal of Heart Failure 2016; 18: 786–95.
21. Klip IT, Comin-Colet J, Voors AA, et al. Iron deficiency in chronic heart failure: an international pooled analysis. American Heart Journal 2013; 165: 575–82.
22. Bruinvels G, Burden R, Brown N, Richards T, Pedlar C. The prevalence and impact of heavy menstrual bleeding among athletes and mass start runners of the 2015 London Marathon. British Journal of Sports Medicine 2016; 50: 566–76.
23. Bruinvels G, Burden R, Brown N, Richards T, Pedlar C. The prevalence and impact of heavy menstrual bleeding (Menorrhagia) in elite and non-elite athletes. PLoS ONE 2016; 11: e0149881.
24. Centres for Disease Control. Iron Deficiency – United States, 1999–2000. Journal of the American Medical Association 2002; 288: 2114–6.
25. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. British Medical Journal 2013; 347: f4822.
26. Klein AA, Collier TJ, Brar MS, et al. The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK – the first Association of Cardiothoracic Anaesthetists national audit. Anaesthesia 2016; 71: 627–35.
27. Muñoz M, Laso-Morales MJ, Gómez-Ramírez S, Cadellas M, Núñez-Matas MJ, García-Erce JA. Pre-operative haemoglobin levels and iron status in a large multicentre cohort of patients undergoing major elective surgery. Anaesthesia 2017; 72: 826–34.